#BEGIN_DRUGCARD DB04310

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
13434-13-4

# ChEBI_ID:
Not Available

# Chemical_Formula:
C19H35N3O5

# Chemical_IUPAC_Name:
(2R)-N-hydroxy-N'-[(2S)-1-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-2-pentylbutanediamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Anti-Bacterial Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide

# HET_ID:
BB2

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C19H35N3O5/c1-4-5-6-8-14(11-16(24)21-27)18(25)20-17(13(2)3)19(26)22-10-7-9-15(22)12-23/h13-15,17,23,27H,4-12H2,1-3H3,(H,20,25)(H,21,24)/t14-,15+,17+/m1/s1

# InChI_Key:
InChIKey=XJLATMLVMSFZBN-VYDXJSESSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C12056

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4310

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
385.4983

# Molecular_Weight_Mono:
385.257671245

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1LQY

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.33

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
3.03e+00 g/l

# Primary_Accession_No:
DB04310

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
443600

# PubChem_Substance_ID:
46505294

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00630

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@](CCCCC)(CC(=O)NO)C(=O)N[C@@]([H])(C(C)C)C(=O)N1CCC[C@@]1([H])CO

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:12 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Cytoplasmic

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_10_Essentiality:
Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
AE004092

# Drug_Target_10_GenBank_ID_Protein:
13621326

# Drug_Target_10_GeneCard_ID:
def

# Drug_Target_10_Gene_Name:
def

# Drug_Target_10_Gene_Sequence:
>1356 bp
ATGACTGAAAATGAACAAATTTTTTGGAACAGGGTCTTGGAATTAGCTCAGAGTCAATTA
AAACAGGCAACTTATGAATTTTTTGTTCATGATGCCCGTCTATTAAAGGTCGATAAGCAT
ATTGCAACTATTTACTTAGATCAAATGAAAGAGCTCTTTTGGGAAAAAAATCTTAAAGAT
GTTATTCTTACTGCTGGTTTTGAAGTTTATAACGCTCAAATTTCTGTTGACTATGTTTTC
GAAGAAGACCTAATGATTGAGCAAAATCAGACCAAAATCAACCAAAAACCTAAGCAGCAA
GCCTTAAATTCTTTGCCTACTGTTACTTCAGATTTAAACTCGAAATATAGTTTTGAAAAC
TTTATTCAAGGAGATGAAAATCGTTGGGCTGTTGCTGCTTCAATAGCAGTAGCTAATACT
CCTGGAACTACCTATAATCCTTTGTTTATTTGGGGTGGCCCTGGGCTTGGAAAAACCCAT
TTATTAAATGCTATTGGTAATTCTGTACTATTAGAAAATCCAAATGCTCGAATTAAATAT
ATCACAGCTGAAAACTTTATTAATGAGTTTGTTATCCATATTCGCCTTGATACCATGGAT
GAATTGAAAGAAAAATTTCGTAATTTAGATTTACTCCTTATTGATGATATCCAATCTTTA
GCTAAAAAAACGCTCTCTGGAACACAAGAAGAGTTCTTTAATACTTTTAATGCACTTCAT
AATAATAACAAACAAATTGTCCTAACAAGCGACCGTACACCAGATCATCTCAATGATTTA
GAAGATCGATTAGTTACTCGTTTTAAATGGGGATTAACAGTCAATATCACACCTCCTGAT
TTTGAAACACGAGTGGCTATTTTGACAAATAAAATTCAAGAATATAACTTTATTTTTCCT
CAAGATACCATTGAGTATTTGGCTGGTCAATTTGATTCTAATGTCAGAGATTTAGAAGGT
GCCTTAAAAGATATTAGTCTGGTTGCTAATTTCAAACAAATTGACACGATTACTGTTGAC
ATTGCTGCCGAAGCTATTCGCGCCAGAAAGCAAGATGGACCTAAAATGACAGTTATTCCC
ATCGAAGAAATTCAAGCGCAAGTTGGAAAATTTTACGGTGTTACCGTCAAAGAAATTAAA
GCTACTAAACGAACACAAAATATTGTTTTAGCAAGACAAGTAGCTATGTTTTTAGCACGT
GAAATGACAGATAACAGTCTTCCTAAAATTGGAAAAGAATTTGGTGGCAGAGACCATTCA
ACAGTACTCCATGCCTATAATAAAATCAAAAACATGATCAGCCAGGACGAAAGCCTTAGG
ATCGAAATTGAAACCATAAAAAACAAAATTAAATAA

# Drug_Target_10_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_10_General_References:
11296296	Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, Primeaux C, Sezate S, Suvorov AN, Kenton S, Lai HS, Lin SP, Qian Y, Jia HG, Najar FZ, Ren Q, Zhu H, Song L, White J, Yuan X, Clifton SW, Roe BA, McLaughlin R: Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4658-63.
16088826	Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Sturdevant DE, Graham MR, Vuopio-Varkila J, Hoe NP, Musser JM: Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. J Infect Dis. 2005 Sep 1;192(5):771-82. Epub 2005 Jul 29.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
6379

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
22862.1

# Drug_Target_10_Name:
Peptide deformylase

# Drug_Target_10_Number_of_Residues:
204

# Drug_Target_10_PDB_ID:
Not Available

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_10_Protein_Sequence:
>Peptide deformylase
MSAQDKLIKPSHLITMDDIIREGNPTLRAVAKEVSLPLCDEDILLGEKMMQFLKHSQDPV
MAEKLGLRAGVGLAAPQIDVSKRIIAVLVPNLPDKEGNPPKEAYSWQEVLYNPKIVSHSV
QDAALSDGEGCLSVDRVVEGYVVRHARVTVDYYDKEGQQHRIKLKGYNAIVVQHEIDHIN
GVLFYDRINAKNPFETKEELLILD

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity)

# Drug_Target_10_SwissProt_ID:
P68771

# Drug_Target_10_SwissProt_Name:
DEF_STRP1

# Drug_Target_10_Synonyms:
PDF
Polypeptide deformylase

# Drug_Target_10_Theoretical_pI:
5.60

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Mitochondrion

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
PDF

# Drug_Target_11_GenBank_ID_Gene:
AF239156

# Drug_Target_11_GenBank_ID_Protein:
11320944

# Drug_Target_11_GeneCard_ID:
PDF

# Drug_Target_11_Gene_Name:
PDF

# Drug_Target_11_Gene_Sequence:
>732 bp
ATGGCCCGGCTGTGGGGCGCGCTGAGTCTTTGGCCACTGTGGGCGGCCGTGCCGTGGGGC
GGGGCGGCAGCCGTCGGTGTCCGGGCTTGCAGCTCCACGGCCGCCCCGGACGGCGTCGAG
GGCCCGGCGCTGCGGCGCTCCTATTGGCGCCACCTGAGGCGTCTGGTGCTGGGTCCTCCC
GAACCGCCGTTCTCGCACGTGTGCCAAGTCGGGGACCCGGTGCTGCGCGGCGTGGCGGCC
CCGGTGGAGCGGGCGCAGCTAGGCGGGCCCGAGCTGCAGCGGCTGACGCAACGGCTGGTC
CAGGTGATGCGGCGGCGGCGCTGCGTGGGCCTAAGCGCGCCGCAGCTGGGGGTGCCGCGG
CAGGTGCTGGCGCTGGAGCTCCCCGAGGCGCTGTGTCGGGAGTGCCCGCCCCGCCAGCGC
GCGCTCCGCCAAATGGAGCCCTTCCCCCTGCGCGTGTTCGTGAACCCCAGCCTGCGAGTG
CTTGACAGCCGCCTGGTCACCTTTCCCGAGGGCTGCGAGAGCGTCGCCGGCTTCCTGGCC
TGCGTGCCCCGCTTCCAGGCGGTGCAGATCTCAGGGCTGGACCCCAATGGAGAACAGGTG
GTGTGGCAGGCGAGCGGGTGGGCAGCCCGCATCATCCAGCACGAGATGGACCACCTGCAG
GGCTGCCTGTTTATTGACAAAATGGACAGCAGGACGTTCACAAACGTCTATTGGATGAAG
GTGAATGACTAA

# Drug_Target_11_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_11_General_References:
11060042	Giglione C, Serero A, Pierre M, Boisson B, Meinnel T: Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms. EMBO J. 2000 Nov 1;19(21):5916-29.

# Drug_Target_11_HGNC_ID:
HGNC:30012

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
3944

# Drug_Target_11_Locus:
16q22.1

# Drug_Target_11_Molecular_Weight:
27014

# Drug_Target_11_Name:
Peptide deformylase, mitochondrial

# Drug_Target_11_Number_of_Residues:
243

# Drug_Target_11_PDB_ID:
Not Available

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_11_Protein_Sequence:
>Peptide deformylase, mitochondrial
MARLWGALSLWPLWAAVPWGGAAAVGVRACSSTAAPDGVEGPALRRSYWRHLRRLVLGPP
EPPFSHVCQVGDPVLRGVAAPVERAQLGGPELQRLTQRLVQVMRRRRCVGLSAPQLGVPR
QVLALELPEALCRECPPRQRALRQMEPFPLRVFVNPSLRVLDSRLVTFPEGCESVAGFLA
CVPRFQAVQISGLDPNGEQVVWQASGWAARIIQHEMDHLQGCLFIDKMDSRTFTNVYWMK
VND

# Drug_Target_11_Reaction:
formyl-L-methionyl peptide + H2O = formate + methionyl peptide

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins

# Drug_Target_11_SwissProt_ID:
Q9HBH1

# Drug_Target_11_SwissProt_Name:
DEFM_HUMAN

# Drug_Target_11_Synonyms:
EC 3.5.1.88
Peptide deformylase, mitochondrial precursor
Polypeptide deformylase

# Drug_Target_11_Theoretical_pI:
9.27

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Y10549

# Drug_Target_1_GenBank_ID_Protein:
2266414

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>555 bp
ATGATCACCATGAAAGATATCATTAAAGAAGGGCATCCGACGCTGCGGAAAGTGGCTGAG
CCCGTTCCGCTGCCGCCTTCAGAGGAAGACAAACGCATTTTGCAAAGCTTGCTTGACTAT
GTGAAAATGAGCCAAGATCCGGAACTGGCGGCCAAATACGGCCTGCGGCCNGGCATCGGC
CTCGCCGCTCCGCAAATCAACGTCTCCAAACGGATGATTGCCGTTCATGTCACTGATGAA
AACGGAACGCTGTACAGCTATGCCTTGTTCAATCCGAAAATCGTCAGCCACTCTGTGCAG
CAATGTTATTTGACGACGGGGGAAGGCTGCCTGTCGGTCGACCGTGATGTGCCCGGATAC
GTACTGCGCTATGCCCGCATCACGGTCACCGGCACGACGCTCGACGGCGAGGAAGTCACC
TTGCGCCTCAAAGGATTGCCGGCCATCGTCTTCCAGCATGAAATCGACCATTTAAACGGC
ATTATGTTTTATGACCGCATCAATCCGGCCGACCCGTTCCAAGTGCCAGACGGGGCGATC
CCGATCGGGCGCTGA

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
9126850	Meinnel T, Lazennec C, Villoing S, Blanquet S: Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion. J Mol Biol. 1997 Apr 4;267(3):749-61.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2992

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
20383

# Drug_Target_1_Name:
Peptide deformylase 2

# Drug_Target_1_Number_of_Residues:
184

# Drug_Target_1_PDB_ID:
1LQY

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_1_Protein_Sequence:
>Peptide deformylase 2
MITMKDIIKEGHPTLRKVAEPVPLPPSEEDKRILQSLLDYVKMSQDPELAAKYGLRPGIG
LAAPQINVSKRMIAVHVTDENGTLYSYALFNPKIVSHSVQQCYLTTGEGCLSVDRDVPGY
VLRYARITVTGTTLDGEEVTLRLKGLPAIVFQHEIDHLNGIMFYDRINPADPFQVPDGAI
PIGR

# Drug_Target_1_Reaction:
formyl-L-methionyl peptide + H2O = formate + methionyl peptide

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions

# Drug_Target_1_SwissProt_ID:
O31410

# Drug_Target_1_SwissProt_Name:
DEF2_GEOSE

# Drug_Target_1_Synonyms:
EC 3.5.1.88
PDF 2
Polypeptide deformylase 2

# Drug_Target_1_Theoretical_pI:
6.35

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
BA000033

# Drug_Target_2_GenBank_ID_Protein:
21204141

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
def

# Drug_Target_2_Gene_Sequence:
>552 bp
TTAAACTTCTACAGCATCTGTATGTGGTTGTAATGGGTGATCTTTGTCAATGTGATCATA
GAACATTACACCATTTAAATGGTCAATTTCATGTTGGAAAACAATTGCTGGATATCCTTT
TAGACGTAATTGTATATCATTACCTTCGATGTCTTTGGCTTTAATTGTAATTCTATTATG
ACGGTGAACTAGACCAGCAACATTATCATCGACACTAAGGCAACCTTCACCAGTTGGTAA
ATAAGCTTCTTGAACGCTATGACTTACAATTTTTGGGTTCACAAGCATATAGTCATAAGA
TTTGCCACTGCCATCATCTGGTATTAAAACAGCAATCATACGTTTAGAAATATTAATTTG
AGGTGCAGCCAAACCAACGCCTGAACGTAAACCATATCGTTTCGCGATTTCCTCATCTTG
ACTATTTACTAAAAACTCTCTCATGGCGATTAATGTTTCTTTTTCTTCTTTAGTTAATGG
TAATTCTAACTCAGCTGCTTTTTGACGCAAAGTTGGATGACCATCTCTAATGATGTCTTT
CATTGTTAACAT

# Drug_Target_2_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_2_General_References:
12044378	Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002 May 25;359(9320):1819-27.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3004

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
20560

# Drug_Target_2_Name:
Peptide deformylase

# Drug_Target_2_Number_of_Residues:
183

# Drug_Target_2_PDB_ID:
1LQW

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_2_Protein_Sequence:
>Peptide deformylase
MLTMKDIIRDGHPTLRQKAAELELPLTKEEKETLIAMREFLVNSQDEEIAKRYGLRSGVG
LAAPQINISKRMIAVLIPDDGSGKSYDYMLVNPKIVSHSVQEAYLPTGEGCLSVDDNVAG
LVHRHNRITIKAKDIEGNDIQLRLKGYPAIVFQHEIDHLNGVMFYDHIDKDHPLQPHTDA
VEV

# Drug_Target_2_Reaction:
formyl-L-methionyl peptide + H2O = formate + methionyl peptide

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions

# Drug_Target_2_SwissProt_ID:
Q8NX78

# Drug_Target_2_SwissProt_Name:
DEF_STAAW

# Drug_Target_2_Synonyms:
EC 3.5.1.88
PDF
Polypeptide deformylase

# Drug_Target_2_Theoretical_pI:
6.03

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasmic

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AE004091

# Drug_Target_3_GenBank_ID_Protein:
9945838

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
def

# Drug_Target_3_Gene_Sequence:
>507 bp
TCACGCCTGCTGTCGATGCTGCTTTTCCAGCTTCTTGCGGATGCGGTCGCGCTTGAGGGT
GGACAGGTAGTCGACGAACAGCTTGCCGTTGAGGTGGTCGCATTCGTGCTGGATGCATAC
CGCCAGCAGGCCTTCGGCGACTTCCTCGAAGGGGTTGCCATCGCGGTCGAGGGCCTTGAT
CCGGACCTTCTGCGGTCGGTCCACGTTCTCGTAGAAGCCGGGTACCGACAGGCAGCCTTC
CTGGTACTGGTCCATATCCTCGGTCAGCGGTTCGAACTCGGGGTTGATGAATACCCTCGG
CTCGGACTTGTCTTCGCTGAGGTCCATGACCACGATGCGCTTGTGCACGTTCACCTGGGT
CGCGGCGAGGCCGATGCCCGGGGCTTCGTACATGGTTTCGAACATGTCGTCGATCAGCTG
GCGCACCGCGTCGTCGACCACCTCCACCGGTTTGGCGATGGTCCGCAGGCGCGGATCGGG
GAATTCGAGAATGTTCAGGATGGCCAT

# Drug_Target_3_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_3_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2708

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
19365

# Drug_Target_3_Name:
Peptide deformylase

# Drug_Target_3_Number_of_Residues:
168

# Drug_Target_3_PDB_ID:
1IX1

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_3_Protein_Sequence:
>Peptide deformylase
MAILNILEFPDPRLRTIAKPVEVVDDAVRQLIDDMFETMYEAPGIGLAATQVNVHKRIVV
MDLSEDKSEPRVFINPEFEPLTEDMDQYQEGCLSVPGFYENVDRPQKVRIKALDRDGNPF
EEVAEGLLAVCIQHECDHLNGKLFVDYLSTLKRDRIRKKLEKQHRQQA

# Drug_Target_3_Reaction:
formyl-L-methionyl peptide + H2O = formate + methionyl peptide

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions

# Drug_Target_3_SwissProt_ID:
Q9I7A8

# Drug_Target_3_SwissProt_Name:
DEF_PSEAE

# Drug_Target_3_Synonyms:
EC 3.5.1.88
PDF
Polypeptide deformylase

# Drug_Target_3_Theoretical_pI:
4.73

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasmic

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X77800

# Drug_Target_4_GenBank_ID_Protein:
471304

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
def

# Drug_Target_4_Gene_Sequence:
>510 bp
ATGTCAGTTTTGCAAGTGTTACATATTCCGGACGAGCGGCTTCGCAAAGTTGCTAAACCG
GTAGAAGAAGTGAATGCAGAAATTCAGCGTATCGTCGATGATATGTTCGAGACGATGTAC
GCAGAAGAAGGTATTGGCCTGGCGGCAACCCAGGTTGATATCCATCAACGTATCATTGTT
ATTGATGTTTCGGAAAACCGTGACGAACGGCTAGTGTTAATCAATCCAGAGCTTTTAGAA
AAAAGCGGCGAAACAGGCATTGAAGAAGGTTGCCTGTCGATCCCTGAACAACGTGCTTTA
GTGCCGCGCGCAGAGAAAGTTAAAATTCGCGCCCTTGACCGCGACGGTAAACCATTTGAA
CTGGAAGCAGACGGTCTGTTAGCCATCTGTATTCAGCATGAGATGGATCACCTGGTCGGC
AAACTGTTTATGGATTATCTGTCACCGCTGAAACAACAACGTATTCGTCAGAAAGTTGAA
AAACTGGATCGTCTGAAAGCCCGGGCTTAA

# Drug_Target_4_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_4_General_References:
10200158	Hao B, Gong W, Rajagopalan PT, Zhou Y, Pei D, Chan MK: Structural basis for the design of antibiotics targeting peptide deformylase. Biochemistry. 1999 Apr 13;38(15):4712-9.
1624424	Guillon JM, Mechulam Y, Schmitter JM, Blanquet S, Fayat G: Disruption of the gene for Met-tRNA(fMet) formyltransferase severely impairs growth of Escherichia coli. J Bacteriol. 1992 Jul;174(13):4294-301.
7896716	Meinnel T, Blanquet S: Enzymatic properties of Escherichia coli peptide deformylase. J Bacteriol. 1995 Apr;177(7):1883-7.
8112305	Mazel D, Pochet S, Marliere P: Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation. EMBO J. 1994 Feb 15;13(4):914-23.
8432722	Meinnel T, Guillon JM, Mechulam Y, Blanquet S: The Escherichia coli fmt gene, encoding methionyl-tRNA(fMet) formyltransferase, escapes metabolic control. J Bacteriol. 1993 Feb;175(4):993-1000.
8845003	Meinnel T, Blanquet S, Dardel F: A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase. J Mol Biol. 1996 Sep 27;262(3):375-86.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9374869	Chan MK, Gong W, Rajagopalan PT, Hao B, Tsai CM, Pei D: Crystal structure of the Escherichia coli peptide deformylase. Biochemistry. 1997 Nov 11;36(45):13904-9.
9565550	Becker A, Schlichting I, Kabsch W, Schultz S, Wagner AF: Structure of peptide deformylase and identification of the substrate binding site. J Biol Chem. 1998 May 8;273(19):11413-6.
9610360	Groche D, Becker A, Schlichting I, Kabsch W, Schultz S, Wagner AF: Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site. Biochem Biophys Res Commun. 1998 May 19;246(2):342-6.
9665852	Dardel F, Ragusa S, Lazennec C, Blanquet S, Meinnel T: Solution structure of nickel-peptide deformylase. J Mol Biol. 1998 Jul 17;280(3):501-13.
9846875	Becker A, Schlichting I, Kabsch W, Groche D, Schultz S, Wagner AF: Iron center, substrate recognition and mechanism of peptide deformylase. Nat Struct Biol. 1998 Dec;5(12):1053-8.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2688

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
19329

# Drug_Target_4_Name:
Peptide deformylase

# Drug_Target_4_Number_of_Residues:
169

# Drug_Target_4_PDB_ID:
1XEO

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_4_Protein_Sequence:
>Peptide deformylase
MSVLQVLHIPDERLRKVAKPVEEVNAEIQRIVDDMFETMYAEEGIGLAATQVDIHQRIIV
IDVSENRDERLVLINPELLEKSGETGIEEGCLSIPEQRALVPRAEKVKIRALDRDGKPFE
LEADGLLAICIQHEMDHLVGKLFMDYLSPLKQQRIRQKVEKLDRLKARA

# Drug_Target_4_Reaction:
formyl-L-methionyl peptide + H2O = formate + methionyl peptide

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions

# Drug_Target_4_SwissProt_ID:
P0A6K3

# Drug_Target_4_SwissProt_Name:
DEF_ECOLI

# Drug_Target_4_Synonyms:
EC 3.5.1.88
PDF
Polypeptide deformylase

# Drug_Target_4_Theoretical_pI:
5.00

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasmic

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AY007227

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
def

# Drug_Target_5_Gene_Sequence:
>552 bp
ATGTTAACAATGAAAGACATCATTAGAGATGGTCATCCAACTTTGCGTCAAAAAGCAGCT
GAGTTAGAATTACCATTAACTAAAGAAGAAAAAGAAACATTAATCGCCATGAGAGAGTTT
TTAGTAAATAGTCAAGATGAGGAAATCGCGAAACGATATGGTTTACGTTCAGGCGTTGGT
TTGGCTGCACCTCAAATTAATATTTCTAAACGTATGATTGCTGTTTTAATACCAGATGAT
GGCAGTGGCAAATCTTATGACTATATGCTTGTGAACCCAAAAATTGTAAGTCATAGCGTT
CAAGAAGCTTATTTACCAACTGGTGAAGGTTGCCTTAGTGTCGATGATAATGTTGCTGGT
CTAGTTCACCGTCATAATAGAATTACAATTAAAGCCAAAGACATCGAAGGTAATGATATA
CAATTACGACTAAAAGGATATCCAGCAATTGTTTTCCAACATGAAATTGACCATTTAAAT
GGTGTAATGTTCTATGATCACATTGACAAAAATCACCCATTACAACCACATACAGATGCT
GTAGAAGTTTAA

# Drug_Target_5_General_Function:
Involved in iron ion binding

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
4337

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
20559

# Drug_Target_5_Name:
Peptide deformylase

# Drug_Target_5_Number_of_Residues:
183

# Drug_Target_5_PDB_ID:
1LQW

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_5_Protein_Sequence:
>Peptide deformylase
MLTMKDIIRDGHPTLRQKAAELELPLTKEEKETLIAMREFLVNSQDEEIAKRYGLRSGVG
LAAPQINISKRMIAVLIPDDGSGKSYDYMLVNPKIVSHSVQEAYLPTGEGCLSVDDNVAG
LVHRHNRITIKAKDIEGNDIQLRLKGYPAIVFQHEIDHLNGVMFYDHIDKNHPLQPHTDA
VEV

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity)

# Drug_Target_5_SwissProt_ID:
P68826

# Drug_Target_5_SwissProt_Name:
DEF_STAAU

# Drug_Target_5_Synonyms:
EC 3.5.1.88
PDF
Polypeptide deformylase

# Drug_Target_5_Theoretical_pI:
6.23

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasmic

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_6_Essentiality:
Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AY040678

# Drug_Target_6_GenBank_ID_Protein:
14626937

# Drug_Target_6_GeneCard_ID:
def

# Drug_Target_6_Gene_Name:
def

# Drug_Target_6_Gene_Sequence:
Not Available

# Drug_Target_6_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_6_General_References:
11976499	Li Y, Ren S, Gong W: Cloning, high-level expression, purification and crystallization of peptide deformylase from Leptospira interrogans. Acta Crystallogr D Biol Crystallogr. 2002 May;58(Pt 5):846-8. Epub 2002 Apr 26.
12712204	Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, Zhang YX, Xiong H, Lu G, Lu LF, Jiang HQ, Jia J, Tu YF, Jiang JX, Gu WY, Zhang YQ, Cai Z, Sheng HH, Yin HF, Zhang Y, Zhu GF, Wan M, Huang HL, Qian Z, Wang SY, Ma W, Yao ZJ, Shen Y, Qiang BQ, Xia QC, Guo XK, Danchin A, Saint Girons I, Somerville RL, Wen YM, Shi MH, Chen Z, Xu JG, Zhao GP: Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature. 2003 Apr 24;422(6934):888-93.
15123432	Zhou Z, Song X, Li Y, Gong W: Unique structural characteristics of peptide deformylase from pathogenic bacterium Leptospira interrogans. J Mol Biol. 2004 May 21;339(1):207-15.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
6375

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
20379.2

# Drug_Target_6_Name:
Peptide deformylase

# Drug_Target_6_Number_of_Residues:
178

# Drug_Target_6_PDB_ID:
1Y6H

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_6_Protein_Sequence:
>Peptide deformylase
MSVRKILRMGDPILRKISEPVTEDEIQTKEFKKLIRDMFDTMRHAEGVGLAAPQIGILKQ
IVVVGSEDNERYPGTPDVPERIILNPVITPLTKDTSGFWEGCLSVPGMRGYVERPNQIRM
QWMDEKGNQFDETIDGYKAIVYQHECDHLQGILYVDRLKDTKLFGFNETLDSSHNVLD

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity)

# Drug_Target_6_SwissProt_ID:
Q93LE9

# Drug_Target_6_SwissProt_Name:
DEF_LEPIN

# Drug_Target_6_Synonyms:
PDF
Polypeptide deformylase

# Drug_Target_6_Theoretical_pI:
4.93

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Cytoplasmic

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_7_Essentiality:
Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
AE016877

# Drug_Target_7_GenBank_ID_Protein:
29893819

# Drug_Target_7_GeneCard_ID:
def1

# Drug_Target_7_Gene_Name:
def1

# Drug_Target_7_Gene_Sequence:
>1341 bp
TTGGAAAATATCTCTGATTTATGGAATAGTGCCTTAAAAGAATTAGAAAAAAAGGTAAGC
AAGCCTAGTTATGAGACATGGTTAAAATCCACAACGGCTCATAACTTGAAGAAAGACGTA
TTAACGATTACAGCTCCGAATGAATTTGCTCGTGACTGGCTAGAATCTCATTACTCCGAA
CTAATTTCAGAAACACTATACGATTTAACAGGGGCAAAATTAGCAATTCGCTTTATTATT
CCCCAAAGTCAAGCTGAAGAGGACATTGATCTGCCTCCAGTTAAGCCGAATCCAGCACAA
GATGATTCAGCTCATTTACCACAGAGCATGTTAAATCCAAAATATACATTCGATACATTT
GTTATTGGCTCTGGTAACCGTTTTGCCCATGCAGCTTCATTAGCTGTAGCTGAGGCGCCA
GCTAAAGCGTATAATCCACTCTTTATTTACGGGGGAGTTGGACTTGGAAAGACACATTTA
ATGCACGCAATTGGTCATTATGTAATTGAACATAATCCAAATGCAAAAGTTGTATATTTA
TCATCAGAAAAATTTACAAATGAATTTATTAACTCTATTCGTGATAATAAAGCTGTTGAT
TTTCGTAATAAATATCGTAACGTAGATGTTTTATTGATAGATGATATTCAATTTCTTGCT
GGAAAAGAACAGACTCAAGAAGAGTTTTTCCATACATTTAACGCATTACACGAAGAAAGT
AAACAAATTGTAATTTCTAGTGACCGACCACCAAAAGAAATTCCAACTTTAGAAGATCGT
CTTCGTTCCCGCTTTGAATGGGGACTTATTACAGACATTACGCCGCCAGATTTAGAGACA
CGAATTGCGATTTTACGCAAAAAAGCAAAAGCTGAAGGGCTTGATATACCAAATGAAGTT
ATGCTTTATATCGCAAATCAAATTGATTCAAATATTCGTGAATTAGAAGGTGCACTTATC
CGAGTTGTAGCTTATTCATCTTTAATTAATAAAGATATTAATGCTGATTTAGCAGCTGAA
GCACTTAAAGATATTATTCCAAATTCTAAGCCGAAAATTATCTCTATTTATGATATTCAA
AAAGCTGTCGGGGACGTTTATCAAGTGAAATTAGAAGATTTTAAAGCGAAAAAACGTACA
AAATCAGTTGCGTTTCCTCGCCAAATTGCAATGTATTTATCGCGCGAGCTTACAGATTCC
TCTTTACCAAAAATAGGTGAAGAATTTGGTGGACGTGATCATACAACAGTTATCCATGCC
CATGAAAAAATCTCTAAACTACTAAAAACCGATACGCAATTACAAAAGCAAGTTGAAGAA
ATTAATGGTATTTTAAAGTAG

# Drug_Target_7_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_7_General_References:
12721630	Ivanova N, Sorokin A, Anderson I, Galleron N, Candelon B, Kapatral V, Bhattacharyya A, Reznik G, Mikhailova N, Lapidus A, Chu L, Mazur M, Goltsman E, Larsen N, D'Souza M, Walunas T, Grechkin Y, Pusch G, Haselkorn R, Fonstein M, Ehrlich SD, Overbeek R, Kyrpides N: Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature. 2003 May 1;423(6935):87-91.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
6376

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
17480.0

# Drug_Target_7_Name:
Peptide deformylase 1

# Drug_Target_7_Number_of_Residues:
156

# Drug_Target_7_PDB_ID:
Not Available

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_7_Protein_Sequence:
>Peptide deformylase 1
MAVLEIIKHPNEVLETPCERVINFDKKLVKLLKDMHETMLIADGVGLAAPQVGVSLQVAV
VDVDDDTGKIELINPSILEKRGEQVGPEGCLSFPGLYGEVERADYIKVRAQNRRGKVFLL
EAEGFLARAIQHEIDHLHGVLFTSKVTRYYEENELE

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity)

# Drug_Target_7_SwissProt_ID:
Q819U0

# Drug_Target_7_SwissProt_Name:
DEF1_BACCR

# Drug_Target_7_Synonyms:
PDF 1
Polypeptide deformylase 1

# Drug_Target_7_Theoretical_pI:
4.79

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasmic

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_8_Essentiality:
Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
AE016877

# Drug_Target_8_GenBank_ID_Protein:
29893819

# Drug_Target_8_GeneCard_ID:
def2

# Drug_Target_8_Gene_Name:
def2

# Drug_Target_8_Gene_Sequence:
>1341 bp
TTGGAAAATATCTCTGATTTATGGAATAGTGCCTTAAAAGAATTAGAAAAAAAGGTAAGC
AAGCCTAGTTATGAGACATGGTTAAAATCCACAACGGCTCATAACTTGAAGAAAGACGTA
TTAACGATTACAGCTCCGAATGAATTTGCTCGTGACTGGCTAGAATCTCATTACTCCGAA
CTAATTTCAGAAACACTATACGATTTAACAGGGGCAAAATTAGCAATTCGCTTTATTATT
CCCCAAAGTCAAGCTGAAGAGGACATTGATCTGCCTCCAGTTAAGCCGAATCCAGCACAA
GATGATTCAGCTCATTTACCACAGAGCATGTTAAATCCAAAATATACATTCGATACATTT
GTTATTGGCTCTGGTAACCGTTTTGCCCATGCAGCTTCATTAGCTGTAGCTGAGGCGCCA
GCTAAAGCGTATAATCCACTCTTTATTTACGGGGGAGTTGGACTTGGAAAGACACATTTA
ATGCACGCAATTGGTCATTATGTAATTGAACATAATCCAAATGCAAAAGTTGTATATTTA
TCATCAGAAAAATTTACAAATGAATTTATTAACTCTATTCGTGATAATAAAGCTGTTGAT
TTTCGTAATAAATATCGTAACGTAGATGTTTTATTGATAGATGATATTCAATTTCTTGCT
GGAAAAGAACAGACTCAAGAAGAGTTTTTCCATACATTTAACGCATTACACGAAGAAAGT
AAACAAATTGTAATTTCTAGTGACCGACCACCAAAAGAAATTCCAACTTTAGAAGATCGT
CTTCGTTCCCGCTTTGAATGGGGACTTATTACAGACATTACGCCGCCAGATTTAGAGACA
CGAATTGCGATTTTACGCAAAAAAGCAAAAGCTGAAGGGCTTGATATACCAAATGAAGTT
ATGCTTTATATCGCAAATCAAATTGATTCAAATATTCGTGAATTAGAAGGTGCACTTATC
CGAGTTGTAGCTTATTCATCTTTAATTAATAAAGATATTAATGCTGATTTAGCAGCTGAA
GCACTTAAAGATATTATTCCAAATTCTAAGCCGAAAATTATCTCTATTTATGATATTCAA
AAAGCTGTCGGGGACGTTTATCAAGTGAAATTAGAAGATTTTAAAGCGAAAAAACGTACA
AAATCAGTTGCGTTTCCTCGCCAAATTGCAATGTATTTATCGCGCGAGCTTACAGATTCC
TCTTTACCAAAAATAGGTGAAGAATTTGGTGGACGTGATCATACAACAGTTATCCATGCC
CATGAAAAAATCTCTAAACTACTAAAAACCGATACGCAATTACAAAAGCAAGTTGAAGAA
ATTAATGGTATTTTAAAGTAG

# Drug_Target_8_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_8_General_References:
12721630	Ivanova N, Sorokin A, Anderson I, Galleron N, Candelon B, Kapatral V, Bhattacharyya A, Reznik G, Mikhailova N, Lapidus A, Chu L, Mazur M, Goltsman E, Larsen N, D'Souza M, Walunas T, Grechkin Y, Pusch G, Haselkorn R, Fonstein M, Ehrlich SD, Overbeek R, Kyrpides N: Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature. 2003 May 1;423(6935):87-91.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
6377

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
20474.2

# Drug_Target_8_Name:
Peptide deformylase 2

# Drug_Target_8_Number_of_Residues:
184

# Drug_Target_8_PDB_ID:
Not Available

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_8_Protein_Sequence:
>Peptide deformylase 2
MLTMKDVIREGDPILRNVAEEVSLPASEEDTTTLKEMIEFVINSQDPEMAEKYSLRPGIG
LAAPQIGVSKKMIAVHVTDADGTLYSHALFNPKIISHSVERTYLQGGEGCLSVDREVPGY
VPRYTRITVKATSINGEEVKLRLKGLPAIVFQHEIDHLNGVMFYDHINKENPFAAPDDSK
PLER

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity)

# Drug_Target_8_SwissProt_ID:
Q819K2

# Drug_Target_8_SwissProt_Name:
DEF2_BACCR

# Drug_Target_8_Synonyms:
PDF 2
Polypeptide deformylase 2

# Drug_Target_8_Theoretical_pI:
5.10

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Cytoplasmic

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_9_Essentiality:
Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
AE016830

# Drug_Target_9_GenBank_ID_Protein:
29342120

# Drug_Target_9_GeneCard_ID:
def

# Drug_Target_9_Gene_Name:
def

# Drug_Target_9_Gene_Sequence:
>1344 bp
ATGCCCGACGTGGAAAGTTTTTGGCATAGCCTTGAAGAAGCCTATCAAGCGATTTTGTCG
GCGCCAAGTTTTGATGCTTGGATTAAAACCACACGCCCTTTGAAATTAGACAACAATCAA
TTGTGGCTAGAAGTCCCTTCTGCAGTTCATCGTGATTACTGGGAAAAAAATCTTTCGGCA
AAAATTGTCGAAACTGGATTTAAATTGACCGGTGCAGAAGTGATGCCCCATTTTGTTGTT
GCCGATGAAAAAGACGCAGCACTGGCACAAGAACTCGAAGAACCTGCCGAAGAAGAAGTT
GTTTTTAGTGAACAAAGTAAAAAAGCGATGCTTAATCCTAAGTACACTTTCGACACCTTC
GTTATTGGTAAAGGAAACCAAATGGCTCATGCTGCAGCGCTTGTTGTTGCCGAGGATCCA
GGTTCGATTTACAATCCCCTTTTCTTCTATGGTGGTGTAGGGTTAGGGAAAACCCATTTG
ATGCATGCTATTGGTCATCAAATGTTAGTGAATCAACCAGATGCCAAAGTCAAATATGTT
AGTAGCGAAACGTTTACGAATGAATTTATCAACTCAATTCAAACAAAGACATCCGAACAA
TTTCGGAAAGAATATCGCAATGTTGACTTATTATTAGTCGATGATATTCAATTTTTGGCG
GAAAAAGAAGCAACATTGGAAGAATTTTTCCATACCTTCAACGATCTTTACAATGAAAAT
AAACAAATTGTTTTAACAAGTGATCGCCCGCCGAATGATATTCCAAAATTACCTGAACGA
TTAGTTTCTCGCTTTGCTTGGGGTTTGTCTGTCGATATCACCCCGCCTGATTTAGAAACA
CGGATTGCAATTTTGCGCAAAAAAGCAGATGCCGAGCGTTTAGAAATTCCGGATGATACA
CTAAGTTATATCGCTGGTCAAATTGATTCCAACATCCGTGAATTAGAGGGTGCTTTGGTC
CGTGTTCAAGCCTTTGCAACTATTAATGGAGAAGATATTACCACTAGTTTAGCGGCGGAC
GCCTTGAAATCTCTAAAATCAGTTGGTAGTAAAAATCAATTGTCCATTTTACAAATTCAA
GAAGAAGTATCCAAATATTATCATGTGCCTCTTAAAGATTTAAAAGGGAAAAAACGGGTG
AAAACAATTGTGGTTCCTCGTCAAATCTCAATGTATCTTGCTAGAGAAATGACCGACAAT
TCCTTGCCAAAAATTGGTGCCGAATTTGGCGGCAAAGATCATACAACGGTGATTCATGCG
CACGAAAAGATTCAGCAATTATTGGAAAAAGATCCAGCGATTCAAAAAGAAGTCAGTGAA
ATTAAAAATTTATTGAACTCTTAG

# Drug_Target_9_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_9_General_References:
12663927	Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM: Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science. 2003 Mar 28;299(5615):2071-4.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
6378

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
20911.8

# Drug_Target_9_Name:
Peptide deformylase

# Drug_Target_9_Number_of_Residues:
187

# Drug_Target_9_PDB_ID:
Not Available

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF01327	Pep_deformylase

# Drug_Target_9_Protein_Sequence:
>Peptide deformylase
MITMKDIIREGNPTLRAVAEEVPVPITEEDRQLGEDMLTFLKNSQDPVKAEELQLRGGVG
LAAPQLDISKRIIAVHVPSNDPENETPSLSTVMYNPKILSHSVQDVCLGEGEGCLSVDRD
VPGYVVRHNKITVSYFDMAGEKHKVRLKNYEAIVVQHEIDHINGIMFYDHINKENPFALK
EGVLVIE

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity)

# Drug_Target_9_SwissProt_ID:
Q82ZJ0

# Drug_Target_9_SwissProt_Name:
DEF_ENTFA

# Drug_Target_9_Synonyms:
PDF
Polypeptide deformylase

# Drug_Target_9_Theoretical_pI:
4.83

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB04310
